{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:49:49Z","timestamp":1789778989887,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd008565","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,10,5]],"date-time":"2011-10-05T00:00:00Z","timestamp":1317772800000}}],"reference-count":81,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008565.pub2","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T16:31:24Z","timestamp":1317227484000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Statins for women with polycystic ovary syndrome not actively trying to conceive"],"prefix":"10.1002","author":[{"given":"Amit D","family":"Raval","sequence":"first","affiliation":[{"name":"Shrimati Kaumudiniben Health Outcome Research Group (SKHORG); Near Depala's Chora Dhrangadhra Gujrat India 363310"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Hunter","sequence":"additional","affiliation":[{"name":"King Edward Memorial Hospital; Department of Obstetrics and Gynaecology; 374 Bagot Rd Perth Western Austraila Australia 6008"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwyn","family":"Stuckey","sequence":"additional","affiliation":[{"name":"Sir Charles Gairdner Hospital; Department of Endocrinology and Diabetes; Perth Australia WA 6009"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J","family":"Hart","sequence":"additional","affiliation":[{"name":"The University of Western Australia, King Edward Memorial Hospital and Fertility Specialists of Western Australia; School of Women's and Infants Health; 374 Bagot Road Subiaco Western Australia Australia 6008"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,10,5]]},"reference":[{"key":"10.1002\/14651858.CD008565.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"74, Abstract no","DOI":"10.1016\/j.fertnstert.2007.07.247","article-title":"Comparison of effects of simvastatin and metformin in women with PCOS: a randomized trial","volume":"88 Suppl 1","author":"Banaszewska","year":"2007","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0002|cit2","doi-asserted-by":"crossref","unstructured":"Banaszewska B Pawelczyk L Spaczynski RZ Duleba AJ Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial Journal of Clinical Endocrinology and Metabolism 2009 4938 45","DOI":"10.1210\/jc.2009-1674"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.fertnstert.2007.07.247","article-title":"Comparison of effects of simvastatin and metformin in women with PCOS: a randomized trial","volume":"88","author":"Banaszewskaa","year":"2007","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0004|cit4","first-page":"i181 P-453 Post","article-title":"Metformin, but not simvastatin, reduces serum levels of advanced glycation end products in women with PCOS: results of a randomized trial","volume":"24 Suppl 1","author":"Duleba","year":"2009","journal-title":"Human Reproduction. European Society of Human Reproduction and Embryology, ESHRE 25th Annual meeting Amsterdam 28 June to 1 July"},{"issue":"3","key":"10.1002\/14651858.CD008565.pub2-BIB0005|cit5","first-page":"S31","article-title":"Randomized trial comparing simvastatin and metformin in women with PCOS: outcomes at six months","volume":"92","author":"Pawelczyk","year":"2008","journal-title":"Fertilty and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD008565.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1210\/jc.2006-1988","article-title":"Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial","volume":"92","author":"Banaszewska","year":"2007","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.fertnstert.2005.07.130","article-title":"Simvastatin improves hyperandrogenism, hyperandrogenemia, LH and lipid profile in women with PCOS: a randomized, cross-over study","volume":"84 Suppl 1","author":"Banaszewska","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0008|cit8","first-page":"i87","article-title":"Simvastatin reduces systemic inflammation and improves endothelial function in women with PCOS; randomized crossover study","volume":"21","author":"Duleba","year":"2006","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0009|cit9","doi-asserted-by":"crossref","unstructured":"Duleba AJ Banaszewska B Spaczynski RZ Pawelczyk L Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial Fertility and Sterility 2006 996 1001","DOI":"10.1016\/j.fertnstert.2005.09.030"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0010|cit10","unstructured":"NIH Annual Building Interdisciplinary Research Careers in Women\u2019s Health (BIRCWH) Scholars Meeting, November2008, Bethesda, Maryland, and the 92nd Annual Endocrine Society Meeting, June 2010, San Diego, California"},{"issue":"5","key":"10.1002\/14651858.CD008565.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.fertnstert.2010.11.040","article-title":"Effects of atorvastatin on vascular function, inflammation, and androgens in women with polycystic ovary syndrome: A double-blind, randomized, placebo-controlled trial","volume":"95","author":"Raja-Khan","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD008565.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2265.2009.03678.x","article-title":"Atorvastatin pretreatment augments the effect of metformin in patients with polycystic ovary syndrome (PCOS)","volume":"72","author":"Sathyapalan","year":"2010","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0013|cit13","doi-asserted-by":"crossref","unstructured":"Sathyapalan T Kilpatrick ES Coady A-M Atkin SL The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study Journal of Clinical Endocrinology and Metabolism 2009 103 8","DOI":"10.1210\/jc.2008-1750"},{"issue":"11","key":"10.1002\/14651858.CD008565.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1373\/clinchem.2010.144014","article-title":"Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome","volume":"56","author":"Sathyapalan","year":"2010","journal-title":"Clinical Chemistry"},{"issue":"9","key":"10.1002\/14651858.CD008565.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2174\/138161211795428821","article-title":"The pluripotential effects of hypolipidemic treatment for polycystic ovary syndrome (PCOS): dyslipidemia, cardiovascular risk factors and beyond","volume":"17","author":"Economou","year":"2011","journal-title":"Current Pharmaceutical Design"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0016|cit16","doi-asserted-by":"crossref","unstructured":"Kaya C Cengiz SD Berker B Demirtas S Cesur M Erdogan G Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study Fertility and Sterility 2009 635 42","DOI":"10.1016\/j.fertnstert.2008.06.006"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0017|cit17","doi-asserted-by":"crossref","unstructured":"Kaya C Pabuccu R Cengiz SD Dunder I Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: a prospective, randomized study Experimental and Clinical Endocrinology and Diabetes 2010 161 6","DOI":"10.1055\/s-0029-1220770"},{"issue":"6","key":"10.1002\/14651858.CD008565.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.fertnstert.2009.11.045","article-title":"Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study","volume":"94","author":"Kazerooni","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0019|cit19","unstructured":"Tapanainen T The Effect of Atorvastatin on Androgen Synthesis, Glucose Metabolism and Inflammation in Women With Polycystic Ovary Syndrome (PCOS). A Placebo Controlled Trial"},{"issue":"2","key":"10.1002\/14651858.CD008565.pub2-BIB0020|cit20","first-page":"126","article-title":"American Association of Clinical Endocrinologists position statement on metabolic and cardiovascular consequences of polycystic ovary syndrome","volume":"11","author":"American Association of Clinical Endocrinologists","year":"2005","journal-title":"Endocrine Practice"},{"issue":"3","key":"10.1002\/14651858.CD008565.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0020-7292(03)00050-X","article-title":"ACOG practice bulletin. Polycystic ovary syndrome. Number 41, December 2002","volume":"80","author":"ACOG","year":"2003","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD008565.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation\/CRP evaluation (PRINCE): a randomized trial and cohort study","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD008565.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0889-8529(05)70079-7","article-title":"Cardiovascular consequences of polycystic ovary syndrome","volume":"28","author":"Amowitz","year":"1999","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0024|cit24","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD008565.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0026-0495(92)90263-A","article-title":"Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies","volume":"41","author":"Aviram","year":"1992","journal-title":"Metabolism: Clinical and Experimental"},{"issue":"4","key":"10.1002\/14651858.CD008565.pub2-BIB0026|cit26","first-page":"347","article-title":"Idiopathic hirsutism","volume":"21","author":"Azziz","year":"2000","journal-title":"Endocrine Reviews"},{"issue":"6","key":"10.1002\/14651858.CD008565.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD008565.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-126-1-199701010-00005","article-title":"Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization","volume":"126","author":"Birdsall","year":"1997","journal-title":"Annals of Internal Medicine"},{"issue":"29","key":"10.1002\/14651858.CD008565.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"17453","DOI":"10.1074\/jbc.271.29.17453","article-title":"Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. Evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme a reductase and cell growth","volume":"271","author":"Carlberg","year":"1996","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1002\/14651858.CD008565.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bpobgyn.2004.05.005","article-title":"Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome","volume":"18","author":"Cattrall","year":"2004","journal-title":"Best Practice & Research. Clinical Obstetrics & Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD008565.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.fertnstert.2005.01.096","article-title":"Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups","volume":"83","author":"Chang","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD008565.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/HYPERTENSIONAHA.106.083972","article-title":"Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome","volume":"49","author":"Chen","year":"2007","journal-title":"Hypertension"},{"issue":"6","key":"10.1002\/14651858.CD008565.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2217\/17455057.4.6.583","article-title":"Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome","volume":"4","author":"Christakou","year":"2008","journal-title":"Women's Health (London, England)"},{"issue":"4","key":"10.1002\/14651858.CD008565.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2265.1989.tb00446.x","article-title":"Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients","volume":"30","author":"Conway","year":"1989","journal-title":"Clinical Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD008565.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jc.2005-1666","article-title":"Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance","volume":"91","author":"Coviello","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD008565.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","article-title":"Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones","volume":"57","author":"Dahlgren","year":"1992","journal-title":"Fertility and Sterility"},{"issue":"8","key":"10.1002\/14651858.CD008565.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0002-9378(75)90081-2","article-title":"Circulating gonadotropins, estrogen and androgens in polycystic ovary disease","volume":"121","author":"DeVane","year":"1975","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD008565.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD008565.pub2-BIB0040|cit40","first-page":"35","article-title":"Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome","volume":"32","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Minerva Endocrinologica"},{"issue":"1","key":"10.1002\/14651858.CD008565.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD008565.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1210\/endo-124-5-2297","article-title":"Mevinolin (lovastatin) inhibits androstenedione production by porcine ovarian theca cells at the level of the 17 alpha-hydroxylase:C-17,20-lyase complex","volume":"124","author":"Engelhardt","year":"1989","journal-title":"Endocrinology"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM - Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0045|cit45","first-page":"275","article-title":"Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic difference","volume":"16","author":"Falsetti","year":"2002","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0046|cit46","unstructured":"Farquhar C Clarke J Lethaby A Thomas J Proctor M Barlow D Cochrane Menstrual Disorders and Subfertility Group In: The Cochrane Library, 2009, Issue 1. Chichester: Wiley-Blackwell. Updated quarterly"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD008565.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1210\/edrv-3-3-299","article-title":"The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands","volume":"3","author":"Gwynne","year":"1982","journal-title":"Endocrine Reviews"},{"issue":"3","key":"10.1002\/14651858.CD008565.pub2-BIB0049|cit49","first-page":"183","article-title":"Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome","volume":"1","author":"Hadi","year":"2005","journal-title":"Vascular Health and Risk Management"},{"issue":"7","key":"10.1002\/14651858.CD008565.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1055\/s-2005-870236","article-title":"Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia","volume":"37","author":"Hahn","year":"2005","journal-title":"Hormone and Metabolic Research"},{"issue":"5","key":"10.1002\/14651858.CD008565.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bpobgyn.2004.05.001","article-title":"Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome","volume":"18","author":"Hart","year":"2004","journal-title":"Best Practice & Research. Clinical Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0052|cit52","unstructured":"Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0053|cit53","first-page":"1","article-title":"Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria","volume":"1","author":"Huang","year":"2009","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.fertnstert.2004.03.037","article-title":"Mevastatin inhibits ovarian theca-interstitial cell proliferation and steroidogenesis","volume":"82 Suppl 3","author":"Izquierdo","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD008565.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2007-992933","article-title":"Statins in the treatment of polycystic ovary syndrome","volume":"26","author":"Kodaman","year":"2008","journal-title":"Seminars in Reproductive Medicine"},{"issue":"13","key":"10.1002\/14651858.CD008565.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2165\/00003495-200868130-00001","article-title":"HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome?","volume":"68","author":"Kodaman","year":"2008","journal-title":"Drugs"},{"issue":"1","key":"10.1002\/14651858.CD008565.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.0000020681.19400.8A","article-title":"Impaired carotid viscoelastic properties in women with polycystic ovaries","volume":"106","author":"Lakhani","year":"2002","journal-title":"Circulation"},{"issue":"25","key":"10.1002\/14651858.CD008565.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1161\/01.CIR.102.25.3104","article-title":"Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription","volume":"102","author":"Laufs","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD008565.pub2-BIB0059|cit59","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"24F","DOI":"10.1016\/j.amjcard.2005.06.009","article-title":"Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme reductase inhibition beyond low-density lipoprotein cholesterol","volume":"96","author":"Liao","year":"2005","journal-title":"American Journal of Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD008565.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-2007-1004966","article-title":"Metabolic profiles and lipoprotein lipid concentrations in non-obese and obese patients with polycystic ovarian disease","volume":"22","author":"Mahabeer","year":"1990","journal-title":"Hormone and Metabolic Research"},{"issue":"2-3","key":"10.1002\/14651858.CD008565.pub2-BIB0062|cit62","first-page":"133","article-title":"Polycystic ovary syndrome and hyperandrogenism as a risk factor for cardiovascular disease","volume":"57","author":"Martikainen","year":"1998","journal-title":"International Journal of Circumpolar Health"},{"issue":"22","key":"10.1002\/14651858.CD008565.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2008.08.039","article-title":"Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients","volume":"52","author":"Mills","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD008565.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.beem.2006.03.003","article-title":"Treatment of hirsutism and acne in hyperandrogenism","volume":"20","author":"Moghetti","year":"2006","journal-title":"Best Practice & Research. Clinical Endocrinology & Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD008565.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/humupd\/dmp008","article-title":"Metabolic features of the reproductive phenotypes of polycystic ovary syndrome","volume":"15","author":"Moran","year":"2009","journal-title":"Human Reproduction Update"},{"issue":"12","key":"10.1002\/14651858.CD008565.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1210\/jc.2002-021816","article-title":"Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome","volume":"88","author":"Orio","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD008565.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1345\/aph.1G659","article-title":"Optimal low-density lipoprotein cholesterol lowering--morning versus evening statin administration","volume":"41","author":"Plakogiannis","year":"2007","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0068|cit68","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM - Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"14","key":"10.1002\/14651858.CD008565.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0071|cit71","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD008565.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3121\/cmr.2.1.13","article-title":"Polycystic ovarian syndrome: diagnosis and management","volume":"2","author":"Sheehan","year":"2004","journal-title":"Clinical Medicine & Research"},{"issue":"6","key":"10.1002\/14651858.CD008565.pub2-BIB0073|cit73","first-page":"1421","article-title":"Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency","volume":"75","author":"Speiser","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD008565.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1677\/joe.0.1510365","article-title":"Insulin-like growth factor I enhancement of steroidogenesis by bovine granulosa cells and thecal cells: dependence on de novo cholesterol synthesis","volume":"151","author":"Spicer","year":"1996","journal-title":"Journal of Endocrinology"},{"issue":"11","key":"10.1002\/14651858.CD008565.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/ENDO:30:1:45","article-title":"Insulin resistance, the metabolic syndrome, diabetes and cardiovascular risk in women with PCOS","volume":"30","author":"Teede","year":"2006","journal-title":"Endocrine"},{"issue":"2","key":"10.1002\/14651858.CD008565.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/hq0202.104081","article-title":"Cellular antioxidant effects of atorvastatin in vitro and in vivo","volume":"22","author":"Wassmann","year":"2002","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"3","key":"10.1002\/14651858.CD008565.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2265.2002.01603.x","article-title":"Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?","volume":"57","author":"Wijeyaratne","year":"2002","journal-title":"Clinical Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD008565.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clinical Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD008565.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/8.3.231","article-title":"Long-term health consequences of PCOS","volume":"8","author":"Wild","year":"2002","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD008565.pub2-BIB0081|cit81","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","volume-title":"Polycystic Ovarian Syndrome","author":"Zawadzki","year":"1992"}],"updated-by":[{"DOI":"10.1002\/14651858.cd008565.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD008565.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:21:32Z","timestamp":1628547692000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD008565.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,10,5]]},"references-count":81,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008565.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD008565.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,5]]}}}